The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Vaxart Inc shares valued at $13,578 were purchased by Watson W. Mark on Jun 18 ’24. At $0.68 per share, Watson W. Mark acquired 20,000 shares. The insider’s holdings grew to 78,125 shares worth approximately $26562.500000000004 following the completion of this transaction.
As published in their initiating research note from Oppenheimer on August 15, 2024, Vaxart Inc [VXRT] has been an Outperform and the price target has been revised to $4. As of November 02, 2021, Cantor Fitzgerald has initiated its “an Overweight” rating for VXRT. Earlier on June 29, 2021, B. Riley Securities downgraded its rating. Their new recommendation was “a Neutral” for VXRT stock which previously was a “a Buy”.
Analyzing VXRT Stock Performance
During the last five days, there has been a drop of approximately -3.29%. Over the course of the year, Vaxart Inc shares have dropped approximately -48.09%. Shares of the company reached a 52-week high of $0.9800 on 01/07/25 and a 52-week low of $0.2850 on 04/09/25. A 50-day SMA is recorded $0.4848, while a 200-day SMA reached $0.6733.
Support And Resistance Levels for Vaxart Inc (VXRT)
According to the 24-hour chart, there is a support level at 0.3366, which, if violated, would cause prices to drop to 0.3294. In the upper region, resistance lies at 0.3560. The next price resistance is at 0.3682. RSI (Relative Strength Index) is 39.15 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0048, which suggests the price will decrease in the coming days. Percent R is at 51.45%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
